COMMUNIQUÉS West-GlobeNewswire

-
Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025
03/06/2025 -
Cartesian Therapeutics Announces New Employment Inducement Grants
03/06/2025 -
Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement
03/06/2025 -
XPOLAR X Series: The Innovative Device Redefining Sports Recovery
03/06/2025 -
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
03/06/2025 -
Philanthropic Donor Funds Cognition Therapeutics’ Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
03/06/2025 -
Glass House Brands Announces June Investor Events
03/06/2025 -
Le Bal Rouge de la Fondation du CUSM amasse 2,106,445 $ pour l’innovation en santé au CUSM
03/06/2025 -
The MUHC Foundation’s Le Bal Rouge Gala raises $2,106,445 million for innovation in health care at the MUHC’s Glen site
03/06/2025 -
Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis
03/06/2025 -
Alignment Healthcare Named to 2025 Fortune 1000 List Following Strong Revenue Growth
03/06/2025 -
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
03/06/2025 -
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/06/2025 -
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference
03/06/2025 -
Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York
03/06/2025 -
Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress
03/06/2025 -
Philips launches intelligent 3D imaging in Europe to empower faster stroke care, helping physicians save time, brain, and lives
03/06/2025 -
IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study
03/06/2025 -
Communiqué de presse : ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps
03/06/2025
Pages